Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1280210-79-8

Post Buying Request

1280210-79-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • SAGECHEM/ tert-butyl pyrrolo[3,4-c]pyrazole-5(2H,4H,6H)-carboxylate /Manufacturer in China

    Cas No: 1280210-79-8

  • No Data

  • No Data

  • Metric Ton/Day

  • SAGECHEM LIMITED
  • Contact Supplier

1280210-79-8 Usage

General Description

2,6-Dihydro-4H-pyrrolo[3,4-c]pyrazole-5-carboxylic acid tert-butyl ester is a chemical compound belonging to the category of Pyrrolotriazolopyrazines, which are bioactive molecules. Its molecular formula is C14H18N4O2 signifying it consists of 14 carbon, 18 hydrogen, four nitrogen, and two oxygen atoms. This chemical is often used as an intermediate in various pharmaceutical syntheses. The hazardous properties and safety information about this chemical are not widely known, highlighting the importance of handling it with care when used in a laboratory or industrial setting. However, it is important to have complete information before using any chemical compound.

Check Digit Verification of cas no

The CAS Registry Mumber 1280210-79-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,0,2,1 and 0 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1280210-79:
(9*1)+(8*2)+(7*8)+(6*0)+(5*2)+(4*1)+(3*0)+(2*7)+(1*9)=118
118 % 10 = 8
So 1280210-79-8 is a valid CAS Registry Number.

1280210-79-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-Butyl 4,6-dihydropyrrolo[3,4-c]pyrazole-5(2H)-carboxylate

1.2 Other means of identification

Product number -
Other names 2-Methyl-2-propanyl 4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carbo xylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1280210-79-8 SDS

1280210-79-8Downstream Products

1280210-79-8Relevant articles and documents

Pyrrolopyrazole derivatives and preparation method thereof, and application of pyrrolopyrazole derivatives in medicines

-

, (2021/03/13)

The invention relates to pyrrolopyrazole derivatives and a preparation method thereof, and application of the pyrrolopyrazole derivatives in medicines. Specifically, the invention relates to novel pyrrolopyrazole derivatives as shown in a general formula (I) in the specification, the preparation method of the pyrrolopyrazole derivatives and application of the pyrrolopyrazole derivatives or pharmaceutical compositions containing the pyrrolopyrazole derivatives as therapeutic agents, particularly as gastric acid secretion inhibitors and potassium ion competitive acid blockers P-CABs) in biological medicines. All the substituents (R1, R2, R3 and R4) and groups (X and Y) in the general formula (I) are as defined in the specification.

Pyrrolopyrazole derivatives and preparation method thereof, and application of pyrrolopyrazole derivatives in medicines

-

, (2021/03/13)

The invention relates to pyrrolopyrazole derivatives and a preparation method thereof, and application of the pyrrolopyrazole derivatives in medicines. Specifically, the invention relates to novel pyrrolopyrazole derivatives as shown in a general formula (I) in the specification, the preparation method of the pyrrolopyrazole derivatives and application of the pyrrolopyrazole derivatives or pharmaceutical compositions containing the pyrrolopyrazole derivatives as therapeutic agents, particularly as gastric acid secretion inhibitors and potassium ion competitive acid blockers P-CABs) in biological medicines. All the substituents (R1, R2, R3, R4 and R5) and a group (X) in the general formula (I) are as defined in the specification.

Preparation method for omarigliptin midbody

-

, (2017/07/19)

The invention provides an efficient and simple preparation method for omarigliptin midbody pyrrole and [3,4-c] pyrazol-5(2H,4H,6H)-carboxylic acid tert-butyl ester, wherein the total recovery ratio is close to 50%. The preparation method is easy to operate, the recovery ratio is higher, three produced wastes are less, and the method is suitable for industrialized production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1280210-79-8